Compound ID | 1321

Update compound information

BVL-GSK098

Synonym(s): Alpibectir

Spectrum of activity: Gram-positive
Details of activity: Transcription factor inhibitor/M. tuberculosis
Combined with other compounds: yes
Institute where first reported: Bioversys AG
Year first mentioned: 2009
Highest developmental phase: Phase 2
Development status: Active (as of 2022)
Chemical structure(s):
Click here for structure editor
Molecular weight: 332.24
Iso. SMILES: C1CN(CCC12CC(=NO2)C(F)(F)F)C(=O)CCC(F)(F)F
InChI Key: ZEAVKHMQTZBUND-UHFFFAOYSA-N
Can. SMILES: C(CC(F)(F)F)C(=O)N1CCC2(CC1)CC(=NO2)C(F)(F)F
InChI: InChI=1S/C12H14F6N2O2/c13-11(14,15)2-1-9(21)20-5-3-10(4-6-20)7-8(19-22-10)12(16,17)18/h1-7H2
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/137500045
Guide to Pharmacology: alpibectir
Citation: https://www.imi.europa.eu/projects-results/project-factsheets/tric-tb

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.